Press Releases
The MC roundtable: how CDMOs are responding to pharma’s top priorities in 2021 (part I)
In a three-part article series, Manufacturing Chemist recently held a virtual roundtable with representatives from a number of top-tier CMOs and CDMOs to discuss how these organizations are responding to pressing issues in the pharmaceutical outsourcing sector. James Choi, our SVP, Chief Information, and Marketing Officer, and Head of Investor Relations, share what we're doing to address flexibility and the operational excellence demands of our customers from our Plant 4 expansion to our advanced digital solutions.
All rights are reserved by the media that published this article.
In a three-part article series, Manufacturing Chemist recently held a virtual roundtable with representatives from a number of top-tier CMOs and CDMOs to discuss how these organizations are responding to pressing issues in the pharmaceutical outsourcing sector. James Choi, our SVP, Chief Information, and Marketing Officer, and Head of Investor Relations, share what we're doing to address flexibility and the operational excellence demands of our customers from our Plant 4 expansion to our advanced digital solutions.
All rights are reserved by the media that published this article.